Filing Details

Accession Number:
0001822359-23-000014
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-19 17:33:08
Reporting Period:
2023-09-15
Accepted Time:
2023-09-19 17:33:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1822359 Docgo Inc. DCGO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1331867 D Ely Tendler C/O Docgo Inc.
35 West 35Th Street, Floor 6
New York NY 10001
General Counsel And Secretary Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-09-15 10,000 $1.59 33,088 No 4 M Direct
Common Stock Disposition 2023-09-15 10,000 $5.91 23,088 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options to purchase Common Stock Disposition 2023-09-15 10,000 $0.00 10,000 $1.59
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,902 No 4 M Direct
Footnotes
  1. Exercise of options effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023 (the "10b5-1 Plan").
  2. Reflects 23,088 restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"), which will vest on December 15, 2023. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan.
  3. Sale of shares effected pursuant to the 10b5-1 Plan.
  4. The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $5.61 to $6.24. Upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
  5. The options vested in three equal annual installments beginning on November 12, 2020 and expire January 1, 2030, subject to the terms of the Option Agreement entered into with Ambulnz Inc. and assumed by the Issuer on November 5, 2021.